MATERIAL SAFETY DATA SHEET
TM
SuGroWTM IRON (Fe~50%)
IRON SUCRATE, GRANULAR (Fe-50%)
I. Product and Manufacturer Information
Material/Product Name: SUGROWTM Iron, (50%-Fe)
Chemical Name: Iron Sucrate (Fe~50%)
Manufacturer's Name
& Address: QC Corporation
5566 Nash Road
Cape Girardeau, MO 63701
Emergency Telephone#: 410-486-0010
Chemtrec#: 800-424-9300
Date Prepared: 12/29/2003
Synonyms: Iron carboxylate; iron oxide, saccharated; iron sugar.
A granulated micronutrient containing 50% iron.
II. Composition/Information on Ingredients
Ingredient CAS No Percent Hazardous Exposure Limits
------------------------------ ------------ -------- ------------ -------------------
No 1
Iron oxide, saccharated 8047-67-4 71-85 OSHA PEL:TWA (oxide fume):
10 mg/m 3; Nuisance particulate
鈥淣ot Otherwise Regulated鈥?: total
dust: 15 mg/m 3; respirable dust:
5 mg/m 3.
Respirable crystalline 14808-60-7 1-2 Yes OSHA PEL:TWA: total: 30
mg/m 3 / SiO2 + 2; respirable: 10
mg/m 3 / SiO2 + 2.
Miscellaneous non- ------------ 13.1-27.5 No OSHA PEL:TWA: Nuisance
hazardous ingredients particulate 鈥淣ot Otherwise
Regulated鈥?: total dust: 15 mg/m 3;
respirable dust: 5 mg/m 3.
1
Iron oxide saccharated 鈥? IARC cancer review: Animal sufficient evidence.
III. Hazards Identification
Emergency Overview
----------------------------
WARNING! MAY CAUSE IRRITATION TO SKIN, EYES AND RESPIRATORY TRACT.
HARMFUL IF SWALLOWED OR INHALED.
Health Rating: 1 - Slight
Flammability Rating: 0 - None
Reactivity Rating: 0 - None
Contact Rating: 1 - Slight
Lab Protective Equip: GOGGLES; GLOVES; LAB COAT
Storage Color Code: Orange (General Storage)
Potential Health Effects
----------------------------------
Inhalation: Causes irritation to the respiratory tract. Symptoms may include coughing, shortness of breath.
Ingestion: Causes irritation to the gastrointestinal tract. Symptoms may include nausea, vomiting and diarrhea.
Low toxicity in small quantities but larger dosages may cause nausea, vomiting, diarrhea, and black stool.
Pink urine discoloration is a strong indicator of iron poisoning. Liver damage, coma, and death from iron
poisoning have been recorded.
Skin Contact: Causes irritation to skin. Symptoms include redness, itching, and pain.
Eye Contact: Causes irritation, redness, scratching of the cornea, and watering of the eye.
Chronic Exposure: Dust generated from this product may contain trace amounts of respirable crystalline silica.
Excessive inhalation of respirable crystalline silica dust may cause a progressive, disabling and sometimes fatal
lung disease called silicosis. Symptoms include cough, shortness of breath, wheezing, non-specific chest illness
and reduced pulmonary function.
Aggravation of Pre-existing Conditions: Persons with pre-existing skin disorders or eye problems, or impaired liver,
kidney or respiratory function may be more susceptible to the effects of the substance.
IV. First Aid Measures
Inhalation: Remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxyen.
Seek medical attention.
Ingestion: Induce vomiting as directed by medical personnel. Never give anything by mouth to an unconscious person.
Seek medical attention.
Skin Contact: Wash affected areas with soap and water. If skin irritation persists, seek medical attention. Wash
clothing before reuse.
Eye Contact: Immediately flush eyes with plenty of water for at least 15 minutes, lifting upper and lower eyelids
occasionally. Seek medical attention.
V. Fire-Fighting Measures
Fire: Not considered to be a fire hazard.
Explosion: Not considered to be an explosion hazard. Sealed containers may rupture when heated.
Fire Extinguishing Media: Use any means suitable for extinguishing surrounding fire.
Special Information: Use protective clothing and breathing equipment appropriate for the surrounding fire.
VI. Accidental Release Measures
Ventilate area of leak or spill. Wear appropriate personal protective equipment as specified in Section 8.
Spills: Sweep up and containerize for reclamation or disposal. Vacuuming or wet sweeping may be used to
avoid dust dispersal.
VII. Handling and Storage
Product requires no special precautions and is stable under normal storage conditions. Protect against physical
damage. Keep separate from strong oxidizers.
VIII. Exposure Controls / Personal Protection
Ventilation System: A system of local and/or general exhaust is recommended to keep employee exposures
below the Airborne Exposure Limits. Local exhaust ventilation is generally preferred because it can control the
emissions of the contaminant at its source, preventing dispersion of it into the general work area. Please refer
to the ACGIH document, Industrial Ventilation, A Manual of Recommended Practices, most recent edition for
details.
Personal Respirators (NIOSH Approved): Use appropiate respiratory protection for respirable particulate based
on consideration of anticipated airborne concentration of particulates. Select a NIOSH approved respirator in
accordance with the requirements of 29 CFR 1910.134.
Skin Protection: Wear impervious protective clothing, including boots, gloves, lab coat, apron or coveralls, as
appropriate, to prevent skin contact.
Eye Protection: Use safety glasses or chemical safety goggles and/or full face shield where dusting is possible.
Maintain eye wash fountain and quick-drench facilities in work area.
Personal Hygiene Practices: Maintain good housekeeping practices. Avoid contact with skin, eyes, and clothing.
Wash hands after handling this product.
IX. Physical and Chemical Properties
Appearance: Black free-flowing granules
Solubility: Slight
Specific Gravity (water=1): 3.4
pH: NA
% Volatiles by volume @ 21C (70oF): 0
Boiling Point: Not applicable.
Melting Point: > 1565 oC (2849 oF)
Vapor Density (Air=1): NA
Vapor Pressure (mm Hg): NA
Evaporation Rate (BuAc=1): NA
X. Stability and Reactivity
Stability: Stable under ordinary conditions of use and storage.
Hazardous Decomposition Products: None identified.
Hazardous Polymerization: Will not occur.
Incompatibilities: Strong oxidizers.
Conditions to Avoid: None known.
XI. Toxicological Information
Iron oxide, saccharated CAS# 8047-67-4 Toxicity Data: (SAX)
Intramuscular-rat TDLo: 148 g/kg/74W:Neoplastic effects;
Subcutaneous-mouse TDLo: 104 g/kg/13W-I: Equivocal tumorigenic agent;
Subcutaneous-mouse TD: 150 g/kgI: Equivocal tumorigenic agent;
Intravenous-mouse LD50: 180 mg/kg.
Silica, quartz CAS# 14808-60-7 Toxic and hazard review: (SAX)
Experimental poison by intratracheal and intravenous routes. An experimental carcinogen, tumorigen, and
neoplastigen. Human systemic effects by inhalation: cough, dyspnea, liver effects. Listed by IARC as a
鈥淜nown Human Carcinogen 鈥? Group 1鈥?. Listed by NTP. No LD50 in RTECS.
Inhalation human: TCLo 16 million particles per cubic centimeter per 8 hours per 17.9 years-intermittent:
Pulmonary system effects;
Inhalation human LCLo: 300 micrograms/m3 per 10 years-intermittent: liver.
Other species toxicity data (NIOSH RTECS):
Intravenous-rat LDLo: 90 mg/kg; Intraperitoneal-rat LDLo: 200 mg/kg;
Intravenous-mouse LDLo: 40 mg/kg: Intravenous-dog LDLo: 20 mg/kg.
Other ingredients: No LD50 or LC50 found for oral, dermal, or inhalation routes of administration.
XII. Ecological Information
Environmental Fate: No information found.
Environmental Toxicity: No information found.
XIII. Disposal Considerations
Whatever cannot be saved for recovery or recycling should be managed in an appropriate and approved
waste disposal facility. Processing, use or contamination of this product may change the waste management
options. State and local disposal regulations may differ from federal disposal regulations. Dispose of
container and unused contents in accordance with federal, state and local requirements.
XIV. Transport Information
US Department of Transportation: Not regulated by DOT as a hazardous material. No label, placard, or
hazard class required. No UN or NA number assigned.
XV. Regulations
Product or components of mixture regulated uner the following lists: SARA TITLE III:
Section 302: No (Extremely Hazardous Substances)
Section 304: No (Emergency Release)
Section 311: Yes, Chronic effects, crystalline silica, MSDS
Section 312: Yes, Tier I / II
Section 313: No (Toxic Chemicals, Toxic Chemical Release Reporting, Form R)
CERCLA Hazardous Substance List, RQ: No
TSCA: Yes. All substances contained in this product are listed in TSCA inventory.
XVI. Other Information
NFPA Ratings: Health: 0 Flammability: 0 Reactivity: 0
Label Precautions:
Avoid breathing dust.
Avoid contact with eyes, skin and clothing.
Wash thoroughly after handling.
Use only with adequate ventilation.
Label First Aid:
In case of eye contact, immediately flush eyes with plenty of water for at least 15 minutes.
In case of skin contact, wash affected areas with soap and water. Wash clothing before reuse.
If inhaled, remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult,
give oxygen. If swallowed, induce vomiting as directed by medical personnel. Never give anything
by mouth to an unconscious person. In all cases, get medical attention.
***************************************************************************************************
QC Corporation provides the information contained herein in good faith but makes no representation as to its handling of the
material by a properly trained person using this product. Individuals receiving the information must exercise their independent
judgment in determining its appropriateness for a particular purpose. QC CORPORATION MAKES NO REPRESENTATIONS
OR WARRANTIES, EITHER EXPRESS OR IMPLIED, INCLUDING WITHOUT LIMITATION ANY WARRANTIES OF
MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE WITH RESPECT TO THE INFORMATION SET FORTH
HEREIN OR THE PRODUCT TO WHICH THE INFORMATION REFERS. ACCORDINGLY, QC CORPORATION WILL NOT
BE RESPONSIBLE FOR DAMAGES RESULTING FROM USE OF OR RELIANCE UPON THIS INFORMATION.
***************************************************************************************************
|